VYOME HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
VYOME HOLDINGS, INC. (HIND) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 208.61 thousand shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2021-03-12
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-12-31 was 13.78K shares, a 244.72% increase year-over-year.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-09-30 was 3.38K shares.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-06-30 was 142.43K shares, a 32.75% decline year-over-year.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-03-31 was 49.02K shares, a 189.15% increase year-over-year.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 208.61K shares, a 281.94% increase from fiscal 2019.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 54.62K shares, a 95.50% decline from fiscal 2018.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2018 was 1.21M shares, a 1201.08% increase from fiscal 2017.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2017 was 93.31K shares, a 80.08% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2020-12-31 | 13.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | 17.16K shares derived: sum of 2 quarters · filed 2021-03-12 | 159.60K shares derived: sum of 3 quarters · filed 2021-03-12 | 208.61K shares 10-K · filed 2021-03-12 |
| 2020-09-30 | 3.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | 145.81K shares derived: sum of 2 quarters · filed 2020-11-06 | 194.83K shares 10-Q · filed 2020-11-06 | 198.83K shares derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-06-30 | 142.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | 191.45K shares 10-Q · filed 2020-07-30 | 195.45K shares derived: sum of 3 quarters · filed 2020-07-30 | 17.33K shares derived: sum of 4 quarters · filed 2020-07-30 |
| 2020-03-31 | 49.02K shares 10-Q · filed 2020-06-19 | 53.01K shares derived: sum of 2 quarters · filed 2020-06-19 | -125.10K shares derived: sum of 3 quarters · filed 2020-06-19 | 86.68K shares derived: sum of 4 quarters · filed 2020-06-19 |
| 2019-12-31 | 4.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -174.12K shares derived: sum of 2 quarters · filed 2020-02-27 | 37.67K shares derived: sum of 3 quarters · filed 2020-02-27 | 54.62K shares 10-K · filed 2020-02-27 |
| 2019-09-30 | -178.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 33.67K shares derived: sum of 2 quarters · filed 2019-11-08 | 50.62K shares 10-Q · filed 2019-11-08 | 307.40K shares derived: sum of 4 quarters · filed 2019-11-08 |
| 2019-06-30 | 211.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | 228.74K shares 10-Q · filed 2019-07-24 | 485.52K shares derived: sum of 3 quarters · filed 2019-07-24 | 712.04K shares derived: sum of 4 quarters · filed 2019-07-24 |
| 2019-03-31 | 16.95K shares 10-Q · filed 2019-05-10 | 273.74K shares derived: sum of 2 quarters · filed 2019-05-10 | 500.26K shares derived: sum of 3 quarters · filed 2019-05-10 | 1.09M shares derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-12-31 | 256.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | 483.31K shares derived: sum of 2 quarters · filed 2019-02-22 | 1.07M shares derived: sum of 3 quarters · filed 2019-02-22 | 1.21M shares 10-K · filed 2019-02-22 |
| 2018-09-30 | 226.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | 811.87K shares derived: sum of 2 quarters · filed 2018-11-02 | 957.24K shares 10-Q · filed 2018-11-02 | 1.01M shares derived: sum of 4 quarters · filed 2018-11-02 |
| 2018-06-30 | 585.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 730.72K shares 10-Q · filed 2018-08-02 | 783.04K shares derived: sum of 3 quarters · filed 2018-08-02 | 804.58K shares derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | 145.37K shares 10-Q · filed 2018-05-10 | 197.69K shares derived: sum of 2 quarters · filed 2018-05-10 | 219.23K shares derived: sum of 3 quarters · filed 2018-05-10 | 238.60K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 52.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | 73.86K shares derived: sum of 2 quarters · filed 2018-03-05 | 93.23K shares derived: sum of 3 quarters · filed 2018-03-05 | 93.31K shares 10-K · filed 2018-03-05 |
| 2017-09-30 | 21.54K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | 40.90K shares derived: sum of 2 quarters · filed 2017-11-03 | 40.98K shares 10-Q · filed 2017-11-03 | 50.90K shares derived: sum of 4 quarters · filed 2017-11-03 |
| 2017-06-30 | 19.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 19.45K shares 10-Q · filed 2017-08-02 | 29.36K shares derived: sum of 3 quarters · filed 2017-08-02 | |
| 2017-03-31 | 79.00 shares 10-Q · filed 2017-05-10 | 9.99K shares derived: sum of 2 quarters · filed 2017-05-10 | ||
| 2016-12-31 | 9.91K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 51.82K shares 10-K · filed 2017-02-23 | ||
| 2016-09-30 | 41.90K shares 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |